Sign in
4

Changes in Ownership

RECURSION PHARMACEUTICALS, INC. Filed Acc 0001209191-23-030383

Director sold 8,885 shares at $5.09 ($45,241)

From the SEC's structured data for this filing

Trades in this filing

Borgeson Blake · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-05-16 Sale : show line 1 in the form −8,885 $5.09 $45,241 7,549,632 D
Open-market sales · 8,885 sh · avg $5.09 · $45,241
Loading xslF345X04/doc4.xml…